Chronic hepatitis B: Whom to treat and for how long? Propositions, challenges, and future directions
10.1007/s12072-010-9163-9
Saved in:
Main Authors: | Ahn, S.H., Chan, H.L.Y., Chen, P.-J., Cheng, J., Goenka, M.K., Hou, J., Lim, S.G., Omata, M., Piratvisuth, T., Xie, Q., Yim, H.J., Yuen, M.-F. |
---|---|
Other Authors: | MEDICINE |
Format: | Review |
Published: |
2011
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/26950 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Comparative characterization of B cells specific for HBV nucleocapsid and envelope proteins in patients with chronic hepatitis B
by: Nina Le Bert, et al.
Published: (2021) -
Maternal HBeAg positivity and viremia associated with umbilical cord blood hepatitis B viremia
by: Lee, L.Y., et al.
Published: (2022) -
Prevention of hepatocellular carcinoma in hepatitis B virus infection
by: Lim, S.G., et al.
Published: (2011) -
Telbivudine: A hepatitis B-specific antiviral
by: Lim, S.G.
Published: (2011) -
Stimulated phospholipid synthesis is key for hepatitis B virus replications
by: Huang, Qingxia, et al.
Published: (2020)